| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.06M | - | |
| Other | 218.9K | $4.97M | - | |
| Other | 167.1K | $3.79M | -10,259 | |
| CFO | 118.3K | $2.69M | - | |
| VP | 62.3K | $1.41M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Ceesay Abraham | Director | Sell | 2,354 | $27.19 | $64,005.26 | -20.7% | -9.5% | - | |
| Aug 7, 2025 | Bigal Marcelo82 | Director | Sell | 4,912 | $23.67 | $116,267.04 | -30.1% | -8.1% | - | |
| Jun 4, 2025 | Riker Lauren76 | Senior Vice President, Finance | Sell | 5,578 | $26.21 | $146,208.16 | -8.6% | +0.9% | -16.0% | |
| Jun 4, 2025 | Williams Kristen76 | Chief Administrative Officer | Sell | 14,376 | $26.24 | $377,226.24 | -8.2% | +0.9% | -16.0% | |
| Jan 6, 2025 | Slonin Jonathan72 | Chief Medical Officer | Sell | 879 | $18.40 | $16,173.60 | -0.9% | +23.0% | +35.9% | |
| Dec 13, 2024 | Gaugler Daryl67 | Chief Operating Officer | Sell | 500 | $19.76 | $9,880.00 | -0.4% | +14.2% | +32.4% | |
| Sep 13, 2024 | Gaugler Daryl67 | Chief Operating Officer | Sell | 500 | $12.86 | $6,430.00 | -0.4% | +51.0% | +106.9% | |
| Aug 16, 2024 | Bigal Marcelo82 | Director | Buy | 1,512 | $13.25 | $20,034.00 | +17.5% | +26.5% | +91.5% | |
| Aug 16, 2024 | Brege Laura62 | Director | Buy | 1,000 | $12.81 | $12,810.00 | +6.0% | +26.5% | +91.5% | |
| Aug 14, 2024 | Yang Michael J. | Director | Buy | 2,000 | $12.90 | $25,800.00 | +38.2% | +34.7% | +100.4% |